麻豆传媒色情片

Journal News

A look into the rice glycoproteome

Ecem Arpaci
By Ecem Arpaci
June 17, 2025

Proteins undergo posttranslational modifications, such as N-glycosylation, during which a sugar chain is added to the amino acid asparagine at specific sites to form a glycoprotein. N-glycosylation aids cell-to-cell communication as well as pathogen interactions in animals, but scientists know little about this modification in plants.

Oryza sativa in a rice field and surrounding natural scenery in Indonesia.
Syariful Msth via Wikimedia Commons
Oryza sativa in a rice field and surrounding natural scenery in Indonesia.

To address this gap, Cong Lei, Xilong Li and Wenjia Li of Yazhouwan National Laboratory and a research team in China developed a metabolic glycan labeling approach, which they used to map N-glycans in rice. In their 麻豆传媒色情片 & Cellular Proteomics , the authors grew Oryza sativa, or rice, with a nutrient mixture containing N-azidoacetylgalactosamine, or GalNAz, an artificial glycan building block they could track over time. GalNAz has a unique chemical group to which the authors attached an affinity tag using click chemistry. This made it possible to study the glycoproteins with liquid chromatography–tandem mass spectrometry.

The team identified hundreds of rice-specific N-linked glycoproteins involved in essential biological processes such as plant growth, starch metabolism and protein processing. In addition, several identified proteins mapped to the endoplasmic reticulum–associated protein degradation, or ERAD, pathways, which maintain a balance between protein folding and degradation. The authors also found the core proteins of this pathway to be N-glycosylated in two human cell lines, suggesting that its regulation is conserved between species.

As changes in N-glycosylation have been linked to disrupted plant development, it is important to shed light on modified proteins and sites. This workflow can be used on other plants to expand our understanding of plant glycoproteomes for agricultural research and biotechnology.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Ecem Arpaci
Ecem Arpaci

Ecem Arpaci is a biochemistry student at Imperial College London and a research intern at Radboud University Medical Center. She is an ASBMB Today volunteer contributor.

Related articles

From the journals: MCP
Vanshika Patel
From the journals: MCP
Farah Aziz Annesha
From the journals: MCP
Courtney Chandler

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto鈥揜yu鈥揗alicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer鈥檚 spaghetti proteins
Profile

Unraveling cancer鈥檚 spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting 鈥渦ndruggable鈥 molecules.

How HCMV hijacks host cells 鈥 and beyond
Profile

How HCMV hijacks host cells 鈥 and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.